Sign up United Kingdom
Proactive Investors - Run By Investors For Investors

Collagen Solutions in “stronger position” after difficult year

The loss of four key customer contracts meant revenues slipped year-on-year, but CEO Jamal Rushdy thinks the changes it made in the wake of those issues leave the company in a better position
surgeons in a hospital
Collagen signed a major customer contract last month

Collagen Solutions PLC (LON:COS) boss Jamal Rushdy has told investors that the company is in a stronger position after what was a difficult year for the regenerative med-tech group.

The loss of contracts with four key customers – valued at over £800,000 a year – meant revenue slipped 6% to £3.83mln in the 12 months ended March 31 (2017: £4.09mln).

READ: Collagen appoints new chief business officer

Underlying losses (LBITDA) widened slightly as well to £1.58mln (2017: £1.26mln). Collagen closed the period with just over £5mln of cash in the bank (2017: £9.0mln).

In response to the challenges, the AIM-quoted firm set about restructuring its business to bolster cash, improve margins and solidify the trajectory to profitability. Collagen also strengthened its board and executive team to help boost its commercial expertise.

The company still managed to bring on board 16 new customers and signed 14 new customer agreements during the year, while last month it signed a “major” contract which will help the top line this time around.

‘Significant year of growth ahead’

“On the one hand, we experienced a difficult year in terms of our sales performance and the necessity to mitigate several unexpected challenges in our core business,” said CEO Rushdy.

“However, I am pleased that our global team, and highly supportive board, faced these challenges head-on and achieved several positive outcomes during the year.

“I am confident the operational improvements and new organisational appointments we have made has put the Company in a much stronger position.”

Chairman David Evans added: “We anticipate that we will have a significant year of growth and change, and it will be a transitional year in terms of new product development and revenue generation.”

View full COS profile View Profile

Collagen Solutions PLC Timeline

Related Articles

Skin beauty
April 19 2018
In a note to clients initiating coverage on SkinBio, the joint ‘house’ broker noted that, as the skin microbiome group operates in a new therapeutic area, there is little market data in the sector
nizoral shampoo
June 19 2018
The new product will be the company's fourth international star brand
March 19 2018
The group has received key permits to allow cannabis - flowers and oils - to be imported into Australia from Aurora Cannabis Inc

No investment advice

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. You further understand that none of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value or suitability of any particular security, portfolio of securities, transaction, investment strategy, or other matter.

You understand that the Site may contain opinions from time to time with regard to securities mentioned in other products, including company related products, and that those opinions may be different from those obtained by using another product related to the Company. You understand and agree that contributors may write about securities in which they or their firms have a position, and that they may trade such securities for their own account. In cases where the position is held at the time of publication and such position is known to the Company, appropriate disclosure is made. However, you understand and agree that at the time of any transaction that you make, one or more contributors may have a position in the securities written about. You understand that price and other data is supplied by sources believed to be reliable, that the calculations herein are made using such data, and that neither such data nor such calculations are guaranteed by these sources, the Company, the information providers or any other person or entity, and may not be complete or accurate.

From time to time, reference may be made in our marketing materials to prior articles and opinions we have published. These references may be selective, may reference only a portion of an article or recommendation, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.

© Proactive Investors 2018

Proactive Investors Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use